Education
About Us
Working with TipRanks
Follow Us
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
KALV Analyst Ratings
Strong Buy
10 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KALV Stock 12 Month Forecast
Average Price Target
$26.33
▲(94.46%Upside)
| Highest Price Target$39.00 | Average Price Target$26.33 | Lowest Price Target$18.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
JonesTrading
$30
Buy
121.57%
Upside
Reiterated
06/03/25
Leerink Partners
$18
Buy
32.94%
Upside
Reiterated
06/02/25
Citizens JMP
$19
Buy
40.32%
Upside
Reiterated
04/23/25
Bank of America Securities
$22
Buy
62.48%
Upside
Reiterated
04/14/25
Needham
$28
Buy
106.79%
Upside
Reiterated
04/08/25
Cantor Fitzgerald
―
Buy
―
Reiterated
03/26/25
Jefferies
$31
Buy
128.95%
Upside
Assigned
03/26/25
Stifel Nicolaus
$39
Buy
188.04%
Upside
Reiterated
03/26/25
TD Cowen
$30
Buy
121.57%
Upside
Reiterated
03/26/25
H.C. Wainwright
$20
Buy
47.71%
Upside
Reiterated
03/14/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
JonesTrading
$30
Buy
121.57%
Upside
Reiterated
06/03/25
Leerink Partners
$18
Buy
32.94%
Upside
Reiterated
06/02/25
Citizens JMP
$19
Buy
40.32%
Upside
Reiterated
04/23/25
Bank of America Securities
$22
Buy
62.48%
Upside
Reiterated
04/14/25
Needham
$28
Buy
106.79%
Upside
Reiterated
04/08/25
Cantor Fitzgerald
―
Buy
―
Reiterated
03/26/25
Jefferies
$31
Buy
128.95%
Upside
Assigned
03/26/25
Stifel Nicolaus
$39
Buy
188.04%
Upside
Reiterated
03/26/25
TD Cowen
$30
Buy
121.57%
Upside
Reiterated
03/26/25
H.C. Wainwright
$20
Buy
47.71%
Upside
Reiterated
03/14/25
Best Analysts Covering KalVista Pharmaceuticals
1 Month
xxx
Success Rate
11/22 ratings generated profit
Average Return
+0.23%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +0.23% per trade.
3 Months
xxx
Success Rate
13/22 ratings generated profit
Average Return
+8.97%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +8.97% per trade.
1 Year
Success Rate
19/22 ratings generated profit
Average Return
+22.53%
reiterated a buy rating 4 days ago
Copying Joseph Schwartz's trades and holding each position for 1 Year would result in 86.36% of your transactions generating a profit, with an average return of +22.53% per trade.
2 Years
xxx
Success Rate
19/22 ratings generated profit
Average Return
+28.48%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 86.36% of your transactions generating a profit, with an average return of +28.48% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KALV Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
Jun 25
Strong Buy
10
11
19
22
19
Buy
0
0
3
4
6
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
11
22
26
25
Each month's total comprises the sum of three months' worth of ratings.
KALV Financial Forecast
KALV Stock Forecast FAQ
What is KALV’s average 12-month price target, according to analysts?
Based on analyst ratings, KalVista Pharmaceuticals’s 12-month average price target is 26.33.
What is KALV’s upside potential, based on the analysts’ average price target?
KalVista Pharmaceuticals has 94.46% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KALV a Buy, Sell or Hold?
KalVista Pharmaceuticals has a consensus rating of Strong Buy which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.
What is KalVista Pharmaceuticals’s price target?
The average price target for KalVista Pharmaceuticals is 26.33. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $39.00 ,the lowest forecast is $18.00. The average price target represents 94.46% Increase from the current price of $13.54.
The highest analyst price target is $39.00 ,the lowest forecast is $18.00. The average price target represents 94.46% Increase from the current price of $13.54.
What do analysts say about KalVista Pharmaceuticals?
KalVista Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of KALV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.